Second and third responses to the same induction regimen in relapsing patients with multiple myeloma
Open Access
- 1 September 1991
- Vol. 68 (5) , 975-980
- https://doi.org/10.1002/1097-0142(19910901)68:5<975::aid-cncr2820680511>3.0.co;2-o
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Peptichemio in pretreated patients with plasmacell neoplasmsEuropean Journal of Cancer and Clinical Oncology, 1986
- Vindesine in refractory multiple myelomaCancer, 1986
- Objective evaluation of the role of vincristine in induction and maintenance therapy for myelomatosis. Medical Research Council Working Party on Leukaemia in AdultsBritish Journal of Cancer, 1985
- Phase II study of teniposide (VM-26) in multiple myelomaAmerican Journal of Clinical Oncology, 1985
- Hexamethylmelamine and prednisone in the treatment of refractory multiple myelomaAmerican Journal of Clinical Oncology, 1982
- Report on the second myelomatosis trial after five years of follow-up.British Journal of Cancer, 1980
- Monoclonal Gammopathy in LymphomaArchives of internal medicine (1960), 1975
- Combination chemotherapy of multiple myeloma with Alkeran, Cytoxan, vincristine, prednisone, and BCNUCancer, 1974
- Melphalan and prednisone: An effective combination for the treatment of multiple myelomaThe American Journal of Medicine, 1973
- Multiple MyelomaPublished by American Medical Association (AMA) ,1964